Devices

FDA Hernia Repair Surgical Mesh Info

FDA has posted an online information page on the surgical mesh used for hernia repair. The page defines hernias and their types and causes, treatment options, surgical mesh, and additional resources.

On the page, FDA discusses non-surgical and surgical options for treating hernias and explains how surgical mesh is used to provide additional support to weakened or damaged tissue. “Hernias have a high likelihood of developing again, and surgeons often use surgical mesh to strengthen the hernia repair and reduce the rate of it happening again,” FDA says. “It is generally accepted that most hernia repair surgeries in the U.S. use mesh.”

The page notes that based on the agency’s analysis of medical device adverse event reports and peer-reviewed scientific literature, the most common adverse events for all surgical repair of hernias, with or without mesh, are pain, infection, hernia recurrence, adhesions, obstruction of the small or large intestine, bleeding, fistula, seroma, and perforation. For mesh repairs, it says, additional adverse events include migration or contraction of the mesh.

Gupta Raises Concerns About Overton’s Independence, Ideology

FDA commissioner nominee Heidi Overton’s responses on vaccines, contraception and abortion medication during her 9/24 Senate confirmation hearing raise concerns that ideology could influence her decision-making if she takes over the agency, MSNBC senior medical analyst Dr. Vin Gupta said Friday. Gupta was particularly critical of Overton’

Overton Confirmation Remains Uncertain After Senate Hearing

FDA commissioner nominee Heidi Overton emerged from her Senate confirmation hearing Thursday (see earlier story) without resolving questions about whether she has enough Republican support to advance — and with a rapidly narrowing window for confirmation before the midterm elections. The Senate Health, Education, Labor and Pensions Committee hearing provided few

FDA Classifies Boston Scientific Imager II Catheter Recall as Class I

FDA has classified Boston Scientific's recall of its Imager II Angiographic Catheters as Class I because a manufacturing problem could cause catheter tips to degrade and detach, potentially resulting in life-threatening complications. The agency announced the Class I classification 9/25, updating an Early Alert it issued

FDA Approves Gazyva for Childhood-Onset Idiopathic Nephrotic Syndrome

FDA has approved Roche’s Gazyva (obinutuzumab) for reducing the risk of relapse in adults and children aged 2 and older with frequently relapsing or steroid-dependent, childhood-onset idiopathic nephrotic syndrome who are in remission. The expanded approval covers the use of the CD20-directed antibody beyond its existing

Read more

Gupta Raises Concerns About Overton’s Independence, Ideology

Overton Confirmation Remains Uncertain After Senate Hearing

FDA Classifies Boston Scientific Imager II Catheter Recall as Class I

FDA Approves Gazyva for Childhood-Onset Idiopathic Nephrotic Syndrome